课题基金 / 基金详情

项目摘要

项目成果

GERALD William FEIGENSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Viruses invade all forms of life, causing diseases in humans including HIV-AIDS. Although the variety of viruses is daunting, all enveloped viruses including those studied here, HIV-1 and Rous Sarcoma Virus (RSV), must associate with the cytoplasmic leaflet of plasma membranes. One difficulty for in vitro studies is the lack of good models of the plasma membrane cytoplasmic leaflet. Another difficulty is that real cells can have membrane heterogeneities on the tens of nanometer size scale on the opposed, exoplasmic leaflet. Both of these experimental issues are addressed in these proposed studies, with a multicomponent model cytoplasmic mixture that can be coupled to a phase-separated lipid mixture in an asymmetric bilayer. This project will explore how three aspects of membrane lipid mixing behavior are related to viral Gag protein binding and assembly: (1) How is the thermodynamic activity of membrane-bound phosphatidylserine controlled by lipid composition, and how is this PS activity connected to Gag binding? (2) How is the thermodynamic activity of Gag's other binding partner, PI(4,5)P2 controlled by the other membrane lipids, and in particular, what factors control the formation of PI(4,5)P2 domains? Are these domains the sites of Gag assembly? (3) The plasma membrane is asymmetric. How does the presence of a phase-separated leaflet that is coupled to the cytoplasmic leaflet change Gag binding and assembly? A theme of this work is that the tendency of membrane lipids to bind or react is described by their thermodynamic activity, and this activity is controlled by all the components of the mixture. This approach provides predictive power to describe the associations of viral Gag structural proteins with their lipid binding partners: Which membrane factors exert control over the interactions among membrane-bound viral Gag proteins? The overall strategy is to combine measurements of lipid thermodynamic activity with measurement of virus protein binding and assembly. Fluorescence microscopy is used to visualize domains of PI(4,5)P2, and to correlate these domains with measured Gag binding and Gag-Gag assembly into its viral lattice.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Lowering line tension with high cholesterol content induces a transition from macroscopic to nanoscopic phase domains in model biomembranes.
高胆固醇含量降低线张力会导致模型生物膜从宏观相域转变为纳米相域。
DOI: 10.1016/j.bbamem.2018.11.010
发表时间: 2019
期刊: Biochimica et biophysica acta. Biomembranes
影响因子: --
作者: [Tsai,Wen-Chyan, Feigenson,GeraldW]
通讯作者: Feigenson,GeraldW
Multivalent Cation-Bridged PI(4,5)P2 Clusters Form at Very Low Concentrations.
多价阳离子桥接 PI(4,5)P2 簇在极低浓度下形成。
DOI: 10.1016/j.bpj.2018.04.048
发表时间: 2018
期刊: Biophysical journal
影响因子: 3.4
作者: [Wen,Yi, Vogt,VolkerM, Feigenson,GeraldW]
通讯作者: Feigenson,GeraldW
DOI: 10.1016/j.dib.2021.106927
发表时间: 2021-04
期刊: Data in brief
影响因子: 1.2
作者: [Enoki TA, Wu J, Heberle FA, Feigenson GW]
通讯作者: Feigenson GW
DOI: 10.1021/acs.langmuir.5b04562
发表时间: 2016-05-24
期刊: Langmuir : the ACS journal of surfaces and colloids
影响因子: --
作者: [Heberle FA, Marquardt D, Doktorova M, Geier B, Standaert RF, Heftberger P, Kollmitzer B, Nickels JD, Dick RA, Feigenson GW, Katsaras J, London E, Pabst G]
通讯作者: Pabst G
Control of Retrovirus Assembly by Membrane Lipid Thermodynamic Activity.
  • 批准号:
    8915268
  • 项目类别:
  • 资助金额:
    $1.25万
  • 财政年份:
    2013
  • 负责人:
    GERALD William FEIGENSON
  • 依托单位:
Control of Retrovirus Assembly by Membrane Lipid Thermodynamic Activity.
  • 批准号:
    8478552
  • 项目类别:
  • 资助金额:
    $25.94万
  • 财政年份:
    2013
  • 负责人:
    GERALD William FEIGENSON
  • 依托单位:
Control of Retrovirus Assembly by Membrane Lipid Thermodynamic Activity.
  • 批准号:
    8730689
  • 项目类别:
  • 资助金额:
    $29.36万
  • 财政年份:
    2013
  • 负责人:
    GERALD William FEIGENSON
  • 依托单位:
Control of Retrovirus Assembly by Membrane Lipid Thermodynamic Activity.
  • 批准号:
    8865646
  • 项目类别:
  • 资助金额:
    $29.34万
  • 财政年份:
    2013
  • 负责人:
    GERALD William FEIGENSON
  • 依托单位:
海外基金